Nadege Pelletier - Feb 1, 2023 Form 4 Insider Report for Vaccitech plc (VACC)

Role
Chief Scientific Officer
Signature
/s/ William Enright, Attorney-in-Fact
Stock symbol
VACC
Transactions as of
Feb 1, 2023
Transactions value $
$0
Form type
4
Date filed
2/24/2023, 04:25 PM
Previous filing
Feb 24, 2023
Next filing
Jan 4, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VACC Share Option (Right to Buy) Award $0 +485K $0.00 485K Feb 1, 2023 Ordinary Shares 485K $2.90 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2 This option shall vest and become exercisable in three equal annual installments, with the first installment vesting on February 1, 2024.